THOMAS J. DeANGELO, CPA
7212 Weathervane Road
Flowery Branch, Georgia 30542
678-828-9298 

SUMMARY OF QUALIFICATIONS

SENIOR FINANCIAL EXECUTIVE with more than 25 years of experience and been
solving major business problems at the senior level. I have performed this in
areas of Sales, Finance and Operations. My main expertise is the three most
critical areas, business operations and management-controls, accountability, and
planning. Innovative and persistent problem solver, who thrives on challenges,
excels under pressure and gets the job done. Versatile, bottom-line oriented and
resourceful team builder who possesses outstanding interpersonal and excellent
communication skills. Quietly assertive/firm but respected leader and coach,
organized/thorough planner and win/win negotiator dealing effectively across all
levels of the organization. Accustomed to a fast pace and multiple projects,
fulfills priorities and balances competing agendas while providing value-added
advice to management enabling them to execute business initiatives to meet their
objectives.

Areas of Expertise

Financial Operations Management including full P&L, U.S. Canadian and UK
financial reporting (GAAP, SEC filings, FASB, management, foreign statutory),
budgeting & forecasting analysis; costing systems development & evaluation,
profit improvement & cost reduction programs; audit, financial & internal control
systems, and committee issues; short & long-term business planning, tax planning
& compliance, treasury, policy & procedure development, risk management &
insurance, and board/investor relations. 
Cash & Working Capital Management including centralized cash administration &
borrowings, cash flow forecasting, credit & collections, inventory management,
capital budgeting, asset financing & debt restructuring, banking relations, and
evaluation of tax saving proposals both domestic and international.
Capital Structure & Funding including public and private company financing
(public offerings, private placements, venture capital, bank & asset based
lending), determining capital structure, financial & cash flow projections, debt
restructuring & loan workout, strategic tax positioning, evaluation of funding
alternatives and selection of preferred sources, development of prospectus,
marketing to potential lenders and investors, negotiation of terms/covenants,
closing and continuing administration.
General Management including directing international operations, real estate,
HR, purchasing, including global outsourcing, consensus building, resource
allocation and organization work flow; evaluating, hiring and retaining talent;
team building, incentive compensation and salary administration, and safety
programs. IT including systems development specification from an end-user
perspective, systems implementation and customization decisions
Strategic Planning/Turnarounds & Workouts including assessment of key issues,
cost & profit drivers, determining strategic alternatives, identifying
opportunities and risks, evaluating & analyzing financial performance, developing
& negotiating partnerships & acquisitions, due diligence, and investment banking
relations.

BUSINESS EXPERIENCE

4/08 to CLARITY IMAGING TECHNOLOGIES INC., Springfield, Massachusetts,
manufacturer of cost 
9/08 effective laser toner cartridges

 Chief Financial Officer

Responsible for the overall financial planning and policies, accounting
practices, financial reporting requirements and relationships with auditors,
Audit Committee and lending institutions. Also responsible for HR, IT, and assist
in the overall operations of the company. 

6/04 to Mark IV Transportation and Logistic, Rochelle Park, New Jersey, is an
expedited, time critical 4/08 delivery company servicing customers along the
Eastern seaboard from it base in Northern New 
 Jersey.

 *Automated the accounting department which resulted in timely reporting and
improved operations
 *Negotiated with a national lending institution a $3 million line of credit to
improve company 
 working capital
 *Authored the company employee handbook
 *Responsible for all vendor contracts and to ensure compliance with company
quality standards

 

 Chief Financial Officer  *  06/04  *  04/08

Responsible for the financial functions of the company including management of
professional staff in finance, accounting, human resources and IT; financial
reporting and analysis, cash management, including bank financing, cost
accounting, tax planning and compliance, and forecasting & budgeting. Also
responsible for business plan development and accompanying financials. financing.
Reported to President/CEO. 

2/03 WJS Consulting Inc., Pembroke Pines, Florida, an IT Consulting Company.
 to 
6/04 Implementing and training of Accounting Software .

08/98 STERILOX TECHNOLOGIES, INC., Radnor, PA, a startup R&D Biotechnology
Company 
 to producing a nontoxic, non-hazardous biocide/sterilant for cold sterilization
processes currently 
1/03 being marketed in Europe. Member of the Board.

 Chief Financial Officer - 1998 to 1/03.

Responsible for the financial functions of the company including management of
professional staff in finance, accounting, human resources and facilities
functions; financial reporting and analysis, cash management, project and cost
accounting, tax planning and compliance, and forecasting & budgeting. Also
responsible for business plan development and accompanying financials; led
efforts to secure equity financing. Managed all global outsourcing for the
purchase of equipment, raw materials and service used in the manufacturing
process. Managed $8.4 million expense budget, 5 professionals and reported to
President/CEO. Member of the Board.

* To support the company through its planned U.S. initial launch and development
period, devised 
and implemented suite of framework policies and procedures. Sourced, recruited
and hired the President, V.P. of Quality Assurance, FDA Consultant, Domestic &
International Controllers, IT Consultant and International Finance/ Operations
Consultant. Result: initial staffing completed within two years; improved
technology and equipment led to 20% increase in international orders.

* To fund U.S. business operations and international expansion of existing
product and services, 
developed funding strategy keyed to raising capital through issuance of common
stock via private placement memorandum. Prepared all necessary documentation with
assistance of outside counsel. Result: raised $8 million to fund the company
through its first three years of operation on an R&D basis.

* To control costs, reviewed the international operations to rationalize assets
and liabilities. 
Undertook further due diligence and operating performance analysis then
reorganized international operations. Result: achieved a smaller, more manageable
operating platform with savings over $1 million annually.

* To remain creditable to the investor community, managed global communication
efforts including 
periodic FDA, operational and design/engineering updates. Result: achieved full
awareness for shareholders and employees; sustained investor confidence through
lengthy regulatory requirement process; obtained very supportive shareholder base
and maintained employee commitment and confidence.

07/82 ISOMEDIX, division of Steris Corporation, Whippany, NJ, A Biotechnology
Company and a leader 
 to in the provisions of contract microbial reduction and sterilization services
with 16 facilities in North 
08/98 America totaling $75 million in annual sales. A publicly traded company
since 1983.

 

 Chief Operating Officer / Chief Financial Officer - 1997 to 1998. CFO - 1993 to
1997.

Full P&L responsibility for finance & accounting, tax, operations, Q&A,
engineering, facilities, HR, IT and safety. Managed all global outsourcing for
the purchase of equipment, raw materials and service used in the manufacturing
process. Managed $35 million operations & expense budget, 21 professionals and
reported to President/CEO. Member of the Board.

* To stay competitive, assessed the financial implementation of competitive
challenges, pricing 
pressures and cost reduction pressure on medical device manufacturers.
Consolidated customers  ' processing requirements in areas where we had multiple
facilities. Result: achieved redistribution of product; staff and production
labor costs dropped $500,000 annually.

* In 1997, managed $120 million transaction in merger of Isomedix, Inc. into
Steris Corporation. 
Led transition team as Isomedix  's Senior Executive in charge of due diligence
proceedings. Facilitated valuation negotiations among parties including Wall
Street investment advising firm and outside accounting firms.

* To respond to market need, assessed the technical and economic feasibility of
expanding the 
company  's irradiation operations to include ethylene Oxide (EtO) sterilization
services. Determined new business viability and funded and expanded additional
services. Result: achieved first year revenue of $2 million and generated $30
million over 10 years.

* To aggressively expand the business, conceived and implemented a strategy
keyed to facility 
expansion, improved operating efficiencies and construction of new facilities.
Managed industrial revenue bond fundraising effort. Result: raised $30 million in
new debt at favorable interest rate; added 6 additional facilities, throughput
increased by 30%-40%.

 * To increase company  's ROI, improved utilization capacity levels at existing
facilities through 
redistribution of product, revised dose mapping, pricing changes and
renegotiation of national contracts. Result: achieved economies of scale that
increased sales in excess of $1 million and reduced expenses by $300,000; ROI
improved 2%.

* To improve IT capabilities to support company  's expansion, managed software
upgrade including 
the implementation